Search

Showing "11155" results for ""

Prevalence of UK HIV drug resistance in antiretroviral-naive falls to 9%

Once-daily arm in maraviroc treatment-naive study terminated

More should be done to reduce burden of HIV on Africans living in the UK, says Health Protection Agency

WHO calls for an end to the marketing of sub-optimal malaria treatments

Hepatitis B genotype linked to degree of liver damage in HIV-positive patients

Statins may not affect CD4 cell count responses to HIV treatment, study suggests

Sustained virological control associated with better immune response to HIV treatment in kids

Experimental HCV protease inhibitor to receive fast track approval

Sexual health clinics will struggle to meet 48 hours appointment target, study finds

Loss of HIV antibodies does not signal HIV clearance, even two years later

CROI: Insulin resistance common in HIV-positive children

CROI: Simplified treatment regimens show promise in HIV-infected children

CROI: Successful PREP trial in monkeys sparks call for more research

CROI: 70% still on first regimen after three years in Khayelitsha, but lactic acidosis a major challenge

CROI: Valaciclovir reduces HIV genital shedding in HIV-positive women

CROI: Rapid scale-up of HIV treatment in Zambia

CROI: Antiretroviral therapy reduces the high incidence of TB in South African children with HIV

CROI: Abacavir may be safer than nevirapine in Africans, DART sub-study suggests

Receive the latest HIV research and conference news

Showing "11155" results for ""

Prevalence of UK HIV drug resistance in antiretroviral-naive falls to 9%

Once-daily arm in maraviroc treatment-naive study terminated

More should be done to reduce burden of HIV on Africans living in the UK, says Health Protection Agency

WHO calls for an end to the marketing of sub-optimal malaria treatments

Hepatitis B genotype linked to degree of liver damage in HIV-positive patients

Statins may not affect CD4 cell count responses to HIV treatment, study suggests

Sustained virological control associated with better immune response to HIV treatment in kids

Experimental HCV protease inhibitor to receive fast track approval

Sexual health clinics will struggle to meet 48 hours appointment target, study finds

Loss of HIV antibodies does not signal HIV clearance, even two years later

CROI: Insulin resistance common in HIV-positive children

CROI: Simplified treatment regimens show promise in HIV-infected children

CROI: Successful PREP trial in monkeys sparks call for more research

CROI: 70% still on first regimen after three years in Khayelitsha, but lactic acidosis a major challenge

CROI: Valaciclovir reduces HIV genital shedding in HIV-positive women

CROI: Rapid scale-up of HIV treatment in Zambia

CROI: Antiretroviral therapy reduces the high incidence of TB in South African children with HIV

CROI: Abacavir may be safer than nevirapine in Africans, DART sub-study suggests

Receive the latest HIV research and conference news